Literature DB >> 27721017

EphA3 promotes malignant transformation of colorectal epithelial cells by upregulating oncogenic pathways.

Mingqi Li1, Cheng Yang1, Xin Liu1, Liang Yuan1, Fubin Zhang1, Muhong Wang1, Dazhuang Miao1, Xinyue Gu1, Shixiong Jiang1, Binbin Cui1, Jinxue Tong2, Zhiwei Yu3.   

Abstract

Ephrin Type-A Receptor 3 (EphA3) belongs to the ephrin receptor subfamily of the protein tyrosine kinase family, and plays an important role in embryogenesis and neurogenesis. This study aimed to investigate the role of EphA3 in promoting malignant transformation of colorectal epithelial cells, and explore underlying molecular mechanisms. Colorectal cancer tissue specimens from 68 patients were analyzed for EphA3 expression. EphA3 expression levels were manipulated in rat colon epithelial cell lines. We found that EphA3 expression level in tumor tissues was associated with patient age (P = 0.015), tumor differentiation (P = 0.001), and lymph node metastasis (P = 0.039). Overexpression of EphA3 and its constitutively active mutants promoted colony formation, migration and invasion, and tumorigenicity of colon epithelial cells in nude mice. The cDNA and lncRNA microarray profiling data revealed that differentially expressed genes and lncRNAs in EphA3 or mutant-transfected cells were associated with cell proliferation, invasion and angiogenesis. Our findings reveal the mechanisms underlying the oncogenic activities of EphA3 in colorectal cells, which could provide novel targets for the prevention, early diagnosis, and treatment of colorectal cancer.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal epithelial cells; EphA3; Mutation; Transformation; Tumorigenicity

Mesh:

Substances:

Year:  2016        PMID: 27721017     DOI: 10.1016/j.canlet.2016.10.004

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  EphA3 Downregulation by Hypermethylation Associated with Lymph Node Metastasis and TNM Stage in Colorectal Cancer.

Authors:  Yong Wang; Zhuoqi Xuan; Baocheng Wang; Dongsheng Zhang; Chuan Zhang; Jiandong Wang; Yueming Sun
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

2.  Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis.

Authors:  Kumud R Poudel; Minna Roh-Johnson; Allen Su; Thuong Ho; Haritha Mathsyaraja; Sarah Anderson; William M Grady; Cecilia B Moens; Maralice Conacci-Sorrell; Robert N Eisenman; Jihong Bai
Journal:  Dev Cell       Date:  2018-06-18       Impact factor: 12.270

3.  The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility.

Authors:  Marwah M Al-Mathkour; Abdulrahman M Dwead; Esma Alp; Ava M Boston; Bekir Cinar
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

4.  Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.

Authors:  Elena Andretta; Fernando Cartón-García; Águeda Martínez-Barriocanal; Priscila Guimarães de Marcondes; Lizbeth M Jimenez-Flores; Irati Macaya; Sarah Bazzocco; Josipa Bilic; Paulo Rodrigues; Rocio Nieto; Stefania Landolfi; Santiago Ramon Y Cajal; Simo Schwartz; Arthur Brown; Higinio Dopeso; Diego Arango
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

Review 5.  The EPH/Ephrin System in Colorectal Cancer.

Authors:  Stavros P Papadakos; Leonidas Petrogiannopoulos; Alexandros Pergaris; Stamatios Theocharis
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

6.  Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166.

Authors:  Henri-François Renard; François Tyckaert; Cristina Lo Giudice; Thibault Hirsch; Cesar Augusto Valades-Cruz; Camille Lemaigre; Massiullah Shafaq-Zadah; Christian Wunder; Ruddy Wattiez; Ludger Johannes; Pierre van der Bruggen; David Alsteens; Pierre Morsomme
Journal:  Nat Commun       Date:  2020-03-19       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.